Proton-to-photon comparative treatment planning guidelines for the Australian context

Scott N Penfold^{1

2

3}, Mikaela Dell'Oro^{4

5

6}, Peter Gorayski^{1

5

7}, Eunji Hwang^{8

9}, Hien Le^{1

5

7}, Melanie Penfold^{1

6}, Jonathan Sykes^{3

8

9}, Hanh Vu^{6

8}, Adam Yeo^{3

10

11}

Affiliations

¹ Australian Bragg Centre for Proton Therapy and Research, Adelaide, South Australia, Australia.
² Department of Physics, University of Adelaide, Adelaide, South Australia, Australia.
³ Particle Therapy Working Group, Australasian College of Physical Scientists and Engineers in Medicine, Sydney, New South Wales, Australia.
⁴ Australian Centre for Quantitative Imaging, School of Medicine, The University of Western Australia, Perth, Western Australia, Australia.
⁵ Cancer Research Institute, University of South Australia, Adelaide, South Australia, Australia.
⁶ Particle Therapy Working Group, Australian Society of Medical Imaging and Radiation Therapy, Melbourne, Victoria, Australia.
⁷ Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
⁸ Department of Radiation Oncology, Sydney West Radiation Oncology Network, Western Sydney Local Health District, Sydney, New South Wales, Australia.
⁹ School of Physics, Institute of Medical Physics, University of Sydney NSW, Sydney, New South Wales, Australia.
¹⁰ Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
¹¹ School of Applied Sciences, RMIT University, Melbourne, Victoria, Australia.

PMID: 36722414
DOI: 10.1111/1754-9485.13510

Proton-to-photon comparative treatment planning guidelines for the Australian context

Scott N Penfold et al. J Med Imaging Radiat Oncol. 2023 Apr.

. 2023 Apr;67(3):320-328.

doi: 10.1111/1754-9485.13510. Epub 2023 Feb 1.

Authors

Affiliations

¹ Australian Bragg Centre for Proton Therapy and Research, Adelaide, South Australia, Australia.
² Department of Physics, University of Adelaide, Adelaide, South Australia, Australia.
³ Particle Therapy Working Group, Australasian College of Physical Scientists and Engineers in Medicine, Sydney, New South Wales, Australia.
⁴ Australian Centre for Quantitative Imaging, School of Medicine, The University of Western Australia, Perth, Western Australia, Australia.
⁵ Cancer Research Institute, University of South Australia, Adelaide, South Australia, Australia.
⁶ Particle Therapy Working Group, Australian Society of Medical Imaging and Radiation Therapy, Melbourne, Victoria, Australia.
⁷ Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
⁸ Department of Radiation Oncology, Sydney West Radiation Oncology Network, Western Sydney Local Health District, Sydney, New South Wales, Australia.
⁹ School of Physics, Institute of Medical Physics, University of Sydney NSW, Sydney, New South Wales, Australia.
¹⁰ Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
¹¹ School of Applied Sciences, RMIT University, Melbourne, Victoria, Australia.

PMID: 36722414
DOI: 10.1111/1754-9485.13510

Abstract

Proton-to-photon comparative treatment planning is a current requirement of Australian Government funding for patients to receive proton beam therapy (PBT) overseas, and a future requirement for Medicare funding of PBT in Australia. Because of the fundamental differences in treatment plan creation and evaluation between PBT and conventional radiation therapy with x-rays (XRT), there is the potential for a lack of consistency in the process of comparing PBT and XRT treatment plans. This may have an impact on patient eligibility assessment for PBT. The objective of these guidelines is to provide a practical reference document for centres performing proton-to-photon comparative planning and thereby facilitate national uniformity.

Keywords: comparative treatment planning; patient selection; proton beam therapy; radiation therapy; robust evaluation.

PubMed Disclaimer

References

1. Medical Treatment Overseas Program [Internet]. [Cited 27 Oct 2021.] Available from URL: https://www1.health.gov.au/internet/main/publishing.nsf/Content/strategi...
1. Medical Services Advisory Committee. Public Summary Document: Application No. 1638 - Proton beam therapy for paediatric and rare cancers, 2021.
1. Hwang EJ, Gorayski P, Le H et al. Particle therapy tumour outcomes: an updated systematic review. J Med Imaging Radiat Oncol 2020; 64: 711-24.
1. Hwang EJ, Gorayski P, Le H et al. Particle therapy toxicity outcomes: a systematic review. J Med Imaging Radiat Oncol 2020; 64: 725-37.
1. Tambas M, Steenbakkers RJHM, van der Laan HP et al. First experience with model-based selection of head and neck cancer patients for proton therapy. Radiother Oncol 2020; 1: 206-13.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Proton-to-photon comparative treatment planning guidelines for the Australian context

Affiliations

Proton-to-photon comparative treatment planning guidelines for the Australian context

Authors

Affiliations

Abstract

References

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources

Full Text Sources